Literature DB >> 25820372

Giant cell angioblastoma of bone: four new cases provide further evidence of its distinct clinical and histopathological characteristics.

Lin Yu1, I Weng Lao, Jian Wang.   

Abstract

Giant cell angioblastoma is a rare locally aggressive vascular neoplasm that occurs predominantly in the soft tissue of infants and children. As very few cases have been reported, the diagnostic criteria of this tumor type have not been clearly defined. The majority of earlier reported cases occurred in soft tissues, only one case being reported to arise in bone. In this study, we describe four additional cases of giant cell angioblastoma with primary presentation in bone. Two cases occurred in males: one in a 23-month-old baby and the other in an 8-year-old boy. The other two cases occurred in adult females, at an age of 37 and 56 years, respectively. The involved sites were right femur, left hip and knee joint, lumbar vertebra, left metacarpus, and phalange. The main presenting symptoms were skeletal pain (n = 3) and limping (n = 1). Clinically, three cases were suspected as tuberculosis and one case as fibrous dysplasia. Histologically, all tumors were composed of infiltrative nodules composed of angiomatous vessels surrounded by spindled-to-ovoid cells and variable numbers of histiocytoid and multinucleate giant cells. By immunohistochemistry, the angiomatous vessels were positive for endothelial markers, whereas surrounding pericytes were positive for actin. The variable histiocytoid cells and multinucleate giant cells showed a histiocytic phenotype. Follow-up revealed no signs of local recurrence or metastasis after surgery, but the follow-up periods were of limited duration. This study illustrates that giant cell angioblastoma represents a locally aggressive endothelial neoplasm characterized by nodular proliferation of small vessels with scattered multinucleate giant cells. It can occur in bone and also in adults, although very rarely.

Entities:  

Mesh:

Year:  2015        PMID: 25820372     DOI: 10.1007/s00428-015-1757-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  16 in total

1.  Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.

Authors:  Jennifer J Marler; Joshua B Rubin; Nikolaus S Trede; Susan Connors; Holcombe Grier; Joseph Upton; John B Mulliken; Judah Folkman
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

2.  Primary vascular tumors of bone: a spectrum of entities?

Authors:  Sofie L J Verbeke; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2011-07-25

3.  Giant cell angioblastoma: three additional occurrences of a distinct pathologic entity.

Authors:  S O Vargas; A R Perez-Atayde; F González-Crussi; H P Kozakewich
Journal:  Am J Surg Pathol       Date:  2001-02       Impact factor: 6.394

4.  An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.

Authors:  Christopher Moosavi; Prakash Jha; Julie C Fanburg-Smith
Journal:  Ann Diagn Pathol       Date:  2007-10       Impact factor: 2.090

5.  Epithelioid hemangioma of bone revisited: a study of 50 cases.

Authors:  G Petur Nielsen; Amitabh Srivastava; Susan Kattapuram; Vikram Deshpande; John X O'Connell; Chas D Mangham; Andrew E Rosenberg
Journal:  Am J Surg Pathol       Date:  2009-02       Impact factor: 6.394

6.  Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.

Authors:  Lisa L Lyons; Paula E North; Fernand Mac-Moune Lai; Mark H Stoler; Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

7.  Pseudomyogenic hemangioendothelioma: report of an additional case with aggressive clinical course.

Authors:  Weiqi Sheng; Yuncui Pan; Jian Wang
Journal:  Am J Dermatopathol       Date:  2013-07       Impact factor: 1.533

8.  Primary pseudomyogenic haemangioendothelioma of bone.

Authors:  W Q Sheng; J Wang
Journal:  Histopathology       Date:  2012-09-11       Impact factor: 5.087

Review 9.  Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

Authors:  M Caraglia; M Marra; P Tagliaferri; S W J Lamberts; S Zappavigna; G Misso; F Cavagnini; G Facchini; A Abbruzzese; L J Hofland; G Vitale
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

10.  Giant cell angioblastoma in an adult: a unique presentation.

Authors:  Susanna Crivelli-Ochsner; Beata Bode-Lesniewska; Yvonne Nussbaumer-Ochsner; Bruno Fuchs
Journal:  Rare Tumors       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.